ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 ...

Global Clinical Trials Review, 2025" offers a comprehensive overview of kidney disease trials worldwide, detailing trial numbers, phases, and status across G7 & E7 countries. This report aids ...

India's DengiAll vaccine trial is nearing completion. ICMR scientists anticipate enrolling 10,500 participants by October ...

Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant Interim ...

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...

After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in ...

Neutra Life Sciences, a newly launched Site Management Organization (SMO) and wholly owned subsidiary of Neutra Corp (OTC: NTRR), is proud to announce a strong and promising start to operations in Q1 ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for ...

University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

US FDA lifts clinical hold on PORTOLA phase 2a trial of Kezar Life Sciences for evaluating zetomipzomib to treat autoimmune hepatitis: South San Francisco, California Friday, July ...

Research published in Science Advances indicates that CVXGA is a promising intranasal vaccine candidate that is safe, immunogenic and potentially effective ...